Valorie Coulter
Family · Houston, TXNPI 1134426265
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.5% of the total across 535 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 24.9% of the total. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 535 payments — averaging $18.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Novartis$1K
- Johnson & Johnson$1K
- E.r. Squibb & Sons, L.L.C.$671
- Sun Pharmaceutical Industries Inc.$625
- Lilly USA, LLC$599
- plus $3K from 22 others
What the payments were for
- Food & beverage$9,69196%
- Education$3524%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 133 | $2,503 |
| Novartis | 115 | $1,409 |
| Johnson & Johnson | 60 | $1,135 |
| E.r. Squibb & Sons, L.L.C. | 35 | $671 |
| Sun Pharmaceutical Industries Inc. | 21 | $625 |
| Lilly USA, LLC | 28 | $599 |
| UCB, Inc. | 23 | $591 |
| Sanofi | 19 | $491 |
| Regeneron Healthcare Solutions, Inc. | 14 | $418 |
| Incyte Corporation | 14 | $282 |
| Pfizer | 11 | $186 |
| Amgen | 8 | $176 |
| Galderma Laboratories, L.p. | 9 | $170 |
| Dermavant Sciences, Inc. | 8 | $144 |
| Regeneron | 3 | $120 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $116 |
| LEO Pharma Inc. | 5 | $99 |
| Arcutis Biotherapeutics, Inc. | 4 | $68 |
| Revance Therapeutics, Inc. | 1 | $42 |
| Boehringer Ingelheim | 1 | $33 |
| Organon | 9 | $32 |
| Merz North America, Inc. | 1 | $24 |
| Mayne Pharma Commercial LLC | 1 | $24 |
| VYNE Pharmaceuticals Inc. | 1 | $23 |
| Tempus AI, Inc | 1 | $19 |
| Sebela Pharmaceuticals Inc. | 1 | $15 |
| Journey Medical Corporation | 1 | $15 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$126
How this compares
$10,043 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 30 | $639 |
| Ketoconazole | 37 | $599 |
| Triamcinolone Acetonide | 25 | $251 |
| Doxycycline Monohydrate | 14 | $223 |
| Mupirocin | 14 | $81 |
Paid to pharmacies, not to this prescriber.
Other family in Houston
- Robin BeachHouston$428K
- Sarah AguilarHouston$199K
- Margaret WhiteHouston$85K
- Cheryl HaseebHouston$42K
- Kendrick ClackHouston$28K
- David WeirDallas$959K
- April LopezMcAllen$417K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.